434 related articles for article (PubMed ID: 32908223)
1. Hyperinsulinaemia in cancer.
Gallagher EJ; LeRoith D
Nat Rev Cancer; 2020 Nov; 20(11):629-644. PubMed ID: 32908223
[TBL] [Abstract][Full Text] [Related]
2. Differential hepatic distribution of insulin receptor substrates causes selective insulin resistance in diabetes and obesity.
Kubota N; Kubota T; Kajiwara E; Iwamura T; Kumagai H; Watanabe T; Inoue M; Takamoto I; Sasako T; Kumagai K; Kohjima M; Nakamuta M; Moroi M; Sugi K; Noda T; Terauchi Y; Ueki K; Kadowaki T
Nat Commun; 2016 Oct; 7():12977. PubMed ID: 27708333
[TBL] [Abstract][Full Text] [Related]
3. [Diabetes, insulin, insulin analogues, and cancer].
Müssig K; Staiger H; Kantartzis K; Fritsche A; Kanz L; Häring HU
Dtsch Med Wochenschr; 2010 May; 135(18):924-9. PubMed ID: 20425680
[TBL] [Abstract][Full Text] [Related]
4. Rethinking the Relationship between Insulin and Cancer.
Vigneri R; Sciacca L; Vigneri P
Trends Endocrinol Metab; 2020 Aug; 31(8):551-560. PubMed ID: 32600959
[TBL] [Abstract][Full Text] [Related]
5. Metabolomics analysis reveals altered metabolites in lean compared with obese adolescents and additional metabolic shifts associated with hyperinsulinaemia and insulin resistance in obese adolescents: a cross-sectional study.
Müllner E; Röhnisch HE; von Brömssen C; Moazzami AA
Metabolomics; 2021 Jan; 17(1):11. PubMed ID: 33438144
[TBL] [Abstract][Full Text] [Related]
6. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
7. Improved glucose metabolism in vitro and in vivo by an allosteric monoclonal antibody that increases insulin receptor binding affinity.
Corbin JA; Bhaskar V; Goldfine ID; Bedinger DH; Lau A; Michelson K; Gross LM; Maddux BA; Kuan HF; Tran C; Lao L; Handa M; Watson SR; Narasimha AJ; Zhu S; Levy R; Webster L; Wijesuriya SD; Liu N; Wu X; Chemla-Vogel D; Lee SR; Wong S; Wilcock D; White ML
PLoS One; 2014; 9(2):e88684. PubMed ID: 24533136
[TBL] [Abstract][Full Text] [Related]
8. The epidemiology and molecular mechanisms linking obesity, diabetes, and cancer.
Ferguson RD; Gallagher EJ; Scheinman EJ; Damouni R; LeRoith D
Vitam Horm; 2013; 93():51-98. PubMed ID: 23810003
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic Links between Obesity, Insulin, and Cancer.
Perry RJ; Shulman GI
Trends Cancer; 2020 Feb; 6(2):75-78. PubMed ID: 32061306
[TBL] [Abstract][Full Text] [Related]
10. Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma.
Chettouh H; Lequoy M; Fartoux L; Vigouroux C; Desbois-Mouthon C
Liver Int; 2015 Oct; 35(10):2203-17. PubMed ID: 26123841
[TBL] [Abstract][Full Text] [Related]
11. Brain insulin signalling in the regulation of energy balance and peripheral metabolism.
Diamant M
Ideggyogy Sz; 2007 Mar; 60(3-4):97-108. PubMed ID: 17451048
[TBL] [Abstract][Full Text] [Related]
12. Co-existence of severe insulin resistance and hyperinsulinaemia in pre-adolescent obese children.
Caprio S; Bronson M; Sherwin RS; Rife F; Tamborlane WV
Diabetologia; 1996 Dec; 39(12):1489-97. PubMed ID: 8960831
[TBL] [Abstract][Full Text] [Related]
13. The serine protease granzyme B as an inflammatory marker, in relation to the insulin receptor cleavage in human obesity and type 2 diabetes mellitus.
El Mesallamy HO; Hamdy NM; Mostafa DM; Amin AI
J Interferon Cytokine Res; 2014 Mar; 34(3):179-86. PubMed ID: 24195710
[TBL] [Abstract][Full Text] [Related]
14. MARCH1 regulates insulin sensitivity by controlling cell surface insulin receptor levels.
Nagarajan A; Petersen MC; Nasiri AR; Butrico G; Fung A; Ruan HB; Kursawe R; Caprio S; Thibodeau J; Bourgeois-Daigneault MC; Sun L; Gao G; Bhanot S; Jurczak MJ; Green MR; Shulman GI; Wajapeyee N
Nat Commun; 2016 Aug; 7():12639. PubMed ID: 27577745
[TBL] [Abstract][Full Text] [Related]
15. [Hyperinsulinism-hypoglycemia in obesity].
Dumitrescu C
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(6):505-20. PubMed ID: 6152068
[No Abstract] [Full Text] [Related]
16. Obesity, type 2 diabetes, and cancer: the insulin and IGF connection.
Cohen DH; LeRoith D
Endocr Relat Cancer; 2012 Oct; 19(5):F27-45. PubMed ID: 22593429
[TBL] [Abstract][Full Text] [Related]
17. Decreased serum microRNA-21 level is associated with obesity in healthy and type 2 diabetic subjects.
Ghorbani S; Mahdavi R; Alipoor B; Panahi G; Nasli Esfahani E; Razi F; Taghikhani M; Meshkani R
Arch Physiol Biochem; 2018 Oct; 124(4):300-305. PubMed ID: 29113498
[TBL] [Abstract][Full Text] [Related]
18. Cellular calcium and magnesium metabolism in the pathophysiology and treatment of hypertension and related metabolic disorders.
Resnick LM
Am J Med; 1992 Aug; 93(2A):11S-20S. PubMed ID: 1387762
[TBL] [Abstract][Full Text] [Related]
19. Insulin secretion and carbohydrate tolerance in childhood obesity.
Molnár D
Klin Padiatr; 1990; 202(3):131-5. PubMed ID: 2192193
[TBL] [Abstract][Full Text] [Related]
20. Diabetes, Obesity, and Breast Cancer.
Kang C; LeRoith D; Gallagher EJ
Endocrinology; 2018 Nov; 159(11):3801-3812. PubMed ID: 30215698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
